Investor · NEW YORK, NY

Matthew Price

Open Matthew in the network graph →

Filings

5

SEC Form D

Connections

15

co-filers

Capital

$72.5M

across filings

Active

Nov 2018

to Dec 2021

Most-connected co-filers (15)

Peter Espig · NEW YORK, NY3 shared Rosita Leong · NEW YORK, NY3 shared John Caouette · NEW YORK, NY3 shared Frances Bonham · NEW YORK, NY3 shared Robert Fallon · NEW YORK, NY2 shared Neil Sunderland · Middleburg Heights, OH2 shared John Porter · NEW YORK, NY2 shared Mike Kwatinetz · Torrance, CA1 shared Tyler Brous · Dallas, TX1 shared Elizabeth Tallett · MALVERN, PA1 shared Boris Van Dyck · Charleston, SC1 shared Matthew J. Waltz · Tempe, AZ1 shared James B. Rosenwald Iii · Redondo Beach, CA1 shared Charles Stuckey · New York, NY1 shared Fallon Robert · New York, NY1 shared

Recent filings (5)

Phosplatin Therapeutics Inc.Dec 2021 · 17 co-filers$37.3M Phosplatin Therapeutics Inc.Dec 2021 · 17 co-filers$37.3M WV Ventures LLCNov 2021 · 4 co-filers$300K WV Ventures LLCNov 2021 · 4 co-filers$300K Phosplatin Therapeutics LLCAug 2020 · 15 co-filers$18.4M Phosplatin Therapeutics LLCAug 2020 · 15 co-filers$18.4M WVV Thomasville Holdings LLCSep 2019 · 3 co-filers$2.5M WVV Thomasville Holdings LLCSep 2019 · 3 co-filers$2.5M Phosplatin Therapeutics LLCNov 2018 · 13 co-filers$16.6M Phosplatin Therapeutics LLCNov 2018 · 13 co-filers$16.6M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Matthew in the interactive graph →